Moderna recovers from 10% dive, but muted expectations weigh on cancer vaccine
FROM THE WIRE · FINANCE.YAHOO.COM
Moderna stock yo-yoed Monday on more muted expectations for its Merck-partnered cancer vaccine, INT. Continue Reading
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralThe stock swings on more cautious expectations for the Merck-partnered cancer vaccine.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Moderna swung on Monday after a 10% dive.
- 02Expectations for the Merck-partnered cancer vaccine INT are more muted.
- 03The stock recovered part of its losses.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Moderna, Inc.199.53 USD+1.18%today -0.28%Neutral Merck & Co., Inc.142.28 USD-0.05%today -2.06%Neutral
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets